Target
Caveolin-1 (Cav-1)
2 abstracts
Abstract
Phase II trial of biologically optimized schedule of gemcitabine and nab-paclitaxel in metastatic pancreatic cancer.Org: The Ohio State University Comprehensive Cancer Center and Department of Internal Medicine, Center for Biostatistics, Department of Biomedical Informatics,
Abstract
Efficacy and safety of lurbinectedin in elderly patients with relapsed SCLC.Org: PharmaMar, Istituto Oncologico Veneto IOV-IRCCS, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain, The Netherlands Cancer Institute, Institutul Oncologic Prof Dr Ion Chiricută and University of Medicine and Pharmacy Iuliu Haţieganu, Cluj-Napoca, Romania,